Article: The [pounds sterling]250 jab that halves the risk of an asthma attack.

Byline: JENNY HOPE

AN ASTHMA jab has been developed which halves the risk of an attack.

The drug, called Xolair, offers hope to the thousands at risk of dying from the disease each year.

At present, the 10 per cent of sufferers with severe asthma have to rely on high doses of powerful steroids which often fail to control their symptoms.

Unlike these drugs, however, Xolair - which is licensed in the UK from today - does not treat the symptoms but interrupts the chain of events that lead to the attack.

Clinical trials have proved that the drug, which is injected into the arm every fortnight, reduces attacks in those with severe ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!